Back to Search Start Over

Evaluating in vivo data for drug metabolism and transport: lessons from Kirchhoff's Laws.

Authors :
Benet LZ
Sodhi JK
Source :
Frontiers in pharmacology [Front Pharmacol] 2024 Nov 05; Vol. 15, pp. 1456677. Date of Electronic Publication: 2024 Nov 05 (Print Publication: 2024).
Publication Year :
2024

Abstract

Mechanistic models of hepatic clearance have been evaluated for more than 50 years, with the first author of this mini-review serving as a co-author of the first paper proposing such a model. However, published quality experimental data are only consistent with the first of these models, designated as the well-stirred model, despite the universal recognition that this model is physiologically unrepresentative of what occurs with respect to liver metabolism and transport. Within the last 3 years, our laboratory has recognized that it is possible to derive clearance equations employing the concepts of Kirchhoff's Laws from physics, independent of the differential equation approach that has been utilized to derive reaction rates in chemistry. Here we review our published studies showing that the equation previously believed to be the well-stirred model, when hepatic basolateral transporters are not clinically relevant, is in fact the general equation for hepatic clearance when only systemic drug concentrations are measured, explaining why all experimental data fit this equation. To demonstrate that the equations deriving the mechanistic models of hepatic elimination for the past 50 years are not valid, we show that when calculating Kp <subscript>uu</subscript> , the ratio of unbound drug concentration in the liver to the unbound concentration of drug in the systemic circulation, for the well-stirred, parallel tube and dispersion models, Kp <subscript>uu</subscript> surprisingly can never exceed 1 and is a function of F <subscript>H</subscript> , the hepatic bioavailability following oral dosing. We believe that knowledgeable drug metabolism scientist and clinical pharmacologist will agree that this outcome is nonsensical.<br />Competing Interests: Author JS was employed by the company Septerna. The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2024 Benet and Sodhi.)

Details

Language :
English
ISSN :
1663-9812
Volume :
15
Database :
MEDLINE
Journal :
Frontiers in pharmacology
Publication Type :
Academic Journal
Accession number :
39564109
Full Text :
https://doi.org/10.3389/fphar.2024.1456677